In this edition we feature:
S1826 trial: N-AVD vs. BV-AVD in advanced-stage cHL
S1826 trial: elderly subgroup analysis
GHSG HD21 trial: PET-adapted BrECADD for elderly advanced-stage cHL
MTV2 for response assessment in advanced-stage HL
LymphoVista HL: a validated MRD assay in HL
NLPHL in Nordic nations
Pembrolizumab maintenance instead of transplant with complete response after P-GVD in relapsed/refractory
Serum TARC dynamics, MTV & clinical response in first-line N-AVD treatment of cHL
GHSG-NLG BVB trial: first-line BV-CAP in advanced-stage HL ≥60 years
A frailty score to predict survival in elderly cHL
Serum TARC + FDG-PET to improve early response assessment in cHL
Risks of toxicities after radiotherapy for HL
Stay up to date with our latest clinical information.
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.